Naoto Katakami
About
Naoto Katakami is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery.
According to data from OpenAlex, Naoto Katakami has authored 171 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Endocrinology, Diabetes and Metabolism, 50 papers in Cardiology and Cardiovascular Medicine and 40 papers in Surgery. Recurrent topics in Naoto Katakami's work include Diabetes Treatment and Management (43 papers), Diabetes Management and Research (39 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (37 papers). Naoto Katakami is often cited by papers focused on Diabetes Treatment and Management (43 papers), Diabetes Management and Research (39 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (37 papers). Naoto Katakami collaborates with scholars based in Japan, United States and Russia. Naoto Katakami's co-authors include Taka‐aki Matsuoka, Munehide Matsuhisa, Hideaki Kaneto, Yoshimitsu Yamasaki, Iichiro Shimomura, Mitsuyoshi Takahara, Kenya Sakamoto, Hideaki Kaneto, Keisuke Kosugi and Dan Kawamori and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.
In The Last Decade
Naoto Katakami
161 papers receiving 4.4k citations
Hit Papers
Peers
Naoto Katakami
Luís Henrique Santos Canani Brazil
Naoki Kashihara Japan
Goji Hasegawa Japan
Carmen Mora‐Fernández Spain
Marleen M. J. van Greevenbroek Netherlands
Sheldon Chen United States
Luigi Gnudi United Kingdom
Shin‐ichi Araki Japan
Hideaki Kaneto Japan
Robin P.F. Dullaart Netherlands
Citations per year, relative to Naoto Katakami Naoto Katakami (= 1×)
peers
Luís Henrique Santos Canani
Countries citing papers authored by Naoto Katakami
Since
Specialization
Citations
This map shows the geographic impact of Naoto Katakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoto Katakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoto Katakami more than expected).
Fields of papers citing papers by Naoto Katakami
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Naoto Katakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoto Katakami. The network helps show where Naoto Katakami may publish in the future.
Co-authorship network of co-authors of Naoto Katakami
This figure shows the co-authorship network connecting the top 25 collaborators of Naoto Katakami. A scholar is included among the top collaborators of Naoto Katakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoto Katakami. Naoto Katakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Waguri, Masako, et al.. (2025). Clinical features of overt versus diagnosed pre‐existing diabetes in pregnancy. Journal of Diabetes Investigation. 16(7). 1325–1328.
2.
Katakami, Naoto, Hirotaka Watanabe, Shugo Sasaki, et al.. (2024). Effect of sodium–glucose cotransporter 2 inhibitors on serum low‐density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus. Journal of Diabetes Investigation. 15(7). 843–850.
3.
Waguri, Masako, et al.. (2024). Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus. Journal of Diabetes Investigation. 15(7). 906–913.
4.
Watanabe, Hirotaka, Mitsuyoshi Takahara, Naoto Katakami, & Iichiro Shimomura. (2022). Changes of HbA1c variability after the switch to a longer‐acting insulin analog in people with type 1 diabetes. Journal of Diabetes Investigation. 14(2). 259–262.
5.
Taya, Naohiro, Naoto Katakami, Hirotaka Watanabe, et al.. (2022). Change in fatty acid composition of plasma triglyceride caused by a 2 week comprehensive risk management for diabetes: A prospective observational study of type 2 diabetes patients with supercritical fluid chromatography/mass spectrometry‐based semi‐target lipidomic analysis. Journal of Diabetes Investigation. 14(1). 102–110.
6.
Katakami, Naoto, Naohiro Taya, Kazuyuki Miyashita, et al.. (2022). Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus. Journal of Diabetes Investigation. 13(9). 1528–1532.
7.
Takahara, Mitsuyoshi, Toshihiko Shiraiwa, Yoshifumi Maeno, et al.. (2022). Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus. BMC Endocrine Disorders. 22(1). 150–150.
8.
Mita, Tomoya, Naoto Katakami, Yosuke Okada, et al.. (2021). Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes. BMJ Open Diabetes Research & Care. 9(1). e001923–e001923.
9.
Takahara, Mitsuyoshi, Toshihiko Shiraiwa, Yoshifumi Maeno, et al.. (2021). Association of obesity, diabetes, and physical frailty with dental and tongue–lip motor dysfunctions in patients with metabolic disease. Obesity Research & Clinical Practice. 15(3). 243–248.
10.
Taya, Naohiro, Naoto Katakami, Hirotaka Watanabe, et al.. (2021). Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis. Journal of Diabetes Investigation. 12(12). 2232–2241.
11.
Fujishima, Yuya, Hitoshi Nishizawa, Takashi Nakamura, et al.. (2021). Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation. JCI Insight. 6(17).
12.
Takahara, Mitsuyoshi, Hirotaka Watanabe, Toshihiko Shiraiwa, et al.. (2021). Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 pandemic in Japan. Journal of Diabetes Investigation. 13(2). 375–385.
13.
Matsuoka, Taka‐aki, Takeshi Miyatsuka, Satsuki Miyazaki, et al.. (2021). Glucotoxicity-induced suppression of Cox6a2 expression provokes β-cell dysfunction via augmented ROS production. Biochemical and Biophysical Research Communications. 556. 134–141.
14.
Watanabe, Hirotaka, Mitsuyoshi Takahara, Naoto Katakami, Taka‐aki Matsuoka, & Iichiro Shimomura. (2020). Preoperative fundus examination in patients with diabetes scheduled for surgery. Journal of Diabetes Investigation. 12(8). 1508–1511.
15.
Fujishima, Yuya, Hitoshi Nishizawa, Hirofumi Nagao, et al.. (2020). Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment. Journal of Diabetes Investigation. 12(8). 1512–1520.
16.
Watanabe, Hirotaka, Mitsuyoshi Takahara, Naoto Katakami, Taka‐aki Matsuoka, & Iichiro Shimomura. (2020). Glycemic control of people with diabetes over months after the 2018 North Osaka Earthquake. Diabetology International. 12(1). 80–86.
17.
Kawamori, Dan, Naoto Katakami, Mitsuyoshi Takahara, et al.. (2019). Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period. Journal of Diabetes Investigation. 11(2). 337–340.
18.
Takashi, Yuichi, Hiroyasu Mori, Kazuyuki Miyashita, et al.. (2019). Circulating osteocalcin as a bone-derived hormone is inversely correlated with body fat in patients with type 1 diabetes. PLoS ONE. 14(5). e0216416–e0216416.
19.
Takahara, Mitsuyoshi, Naoto Katakami, Toshihiko Shiraiwa, et al.. (2018). Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L. Acta Diabetologica. 56(3). 309–319.
20.
Irie, Yoko, Naoto Katakami, Hideaki Kaneto, et al.. (2014). The risk factors associated with ultrasonic tissue characterization of carotid plaque in type 2 diabetic patients. Journal of Diabetes and its Complications. 28(4). 523–527.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Luís Henrique Santos Canani Breakdown of academic impact, for papers by Naoki Kashihara Breakdown of academic impact, for papers by Goji Hasegawa Breakdown of academic impact, for papers by Carmen Mora‐Fernández Breakdown of academic impact, for papers by Marleen M. J. van Greevenbroek Breakdown of academic impact, for papers by Sheldon Chen Breakdown of academic impact, for papers by Luigi Gnudi Breakdown of academic impact, for papers by Shin‐ichi Araki Breakdown of academic impact, for papers by Hideaki Kaneto Breakdown of academic impact, for papers by Robin P.F. Dullaart